Skip to main content

SuperArray Bioscience Changes Name

NEW YORK (GenomeWeb News) – SuperArray Bioscience said today that it has changed its name to SABiosciences and has moved into a new facility in Frederick, Md., that is three times larger than its previous location in the same city.
 
The new building has 43,000 square feet and supports 150 full-time employees.
 
The firm said that the name change and relocation reflects the firm’s expansion into additional technologies beyond gene expression analysis.
 
“We are not just a microarray company anymore,” SABiosciences VP of Sales and Marketing Dave Martz said in a statement. “To provide our vision of a systems biology approach in a post-genome era, SABiosciences now also offers gene function analysis solutions such as RNA interference, ELISA kits, cell-based reporter assays, as well as chromatin immunoprecipitation and other products for epigenomics research.”

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.